Listed

Red Violet, Inc.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 11, 2020 and accepted by EDGAR at Aug 11, 2020, 16:55 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$7.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-30$16.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Operating income3 months2020-04-01 to 2020-06-30−$2.5mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$4.0mus-gaap:OperatingIncomeLoss
Net income3 months2020-04-01 to 2020-06-30−$2.5mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30−$4.0mus-gaap:NetIncomeLoss
Operating cash flow6 months2020-01-01 to 2020-06-30$3.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$61.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-06-30$13.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$17.3mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$52.1mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$4.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$8.4mus-gaap:Liabilities
Long-term debtAt period end2020-06-30$1.4mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-06-30$702.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-06-30$43.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-039351. Last ingested by Listed: Nov 13, 2026, 16:59 ET. Listed shows no prices and gives no investment advice.